Try Fund Library Premium
Free with a 30 day trial!
Gain access to
- Unlimited Watchlists
- Advanced Search Filtering
- Fund Comparisons
- Portfolio Scenarios
- Customizable PDF Reports
- Portfolio Rebalancer new
Fidelity Global Health Care Fund Series B
Health Care Equity
Click for more information on Fundata’s FundGrade
FundGrade E
Click for more information on Fundata’s FundGrade.
Click for more information on Fundata’s ESG Grade
Fundata ESG Grade A
Click for more information on Fundata’s ESG Grade.
|
NAVPS (05-13-2026) |
$59.54 |
|---|---|
| Change |
-$0.01
(-0.02%)
|
As at April 30, 2026
As at March 31, 2026
As at April 30, 2026
Loading......
Legend
Compare Options
Fund Returns
Inception Return (June 05, 1997): 6.47%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | -3.07% | -9.36% | -6.85% | -9.56% | -5.34% | -5.37% | -1.02% | 0.51% | 0.74% | 2.39% | 4.49% | 5.74% | 5.11% | 5.90% |
| Benchmark | -2.20% | -5.11% | -0.92% | -4.87% | 5.78% | 3.80% | 4.47% | 5.87% | 5.46% | 5.98% | 7.70% | 8.37% | 7.92% | 8.80% |
| Category Average | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Category Rank | 32 / 53 | 41 / 51 | 46 / 51 | 41 / 51 | 48 / 51 | 44 / 49 | 35 / 43 | 35 / 41 | 26 / 39 | 28 / 36 | 23 / 35 | 20 / 32 | 17 / 29 | 18 / 29 |
| Quartile Ranking | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 4 | 3 | 3 | 3 | 3 |
Monthly Return
| Return % | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | -3.40% | 0.65% | -1.91% | 3.02% | 0.81% | 2.61% | 5.56% | -2.43% | -0.23% | 0.83% | -7.26% | -3.07% |
| Benchmark | -3.48% | 0.91% | -0.60% | 4.16% | 2.38% | 3.42% | 7.21% | -2.85% | 0.25% | 3.41% | -6.17% | -2.20% |
Best Monthly Return Since Inception
11.29% (January 2015)
Worst Monthly Return Since Inception
-10.46% (September 1999)
Calendar Return (%)
| Return % | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | -15.18% | 10.92% | 13.84% | 18.30% | 9.18% | 19.22% | -7.74% | 2.95% | 7.02% | -0.55% |
| Benchmark | -8.68% | 14.01% | 11.82% | 17.06% | 13.59% | 15.28% | -1.72% | 1.42% | 9.95% | 9.64% |
| Category Average | - | - | - | - | - | - | - | - | - | - |
| Quartile Ranking | 3 | 2 | 1 | 2 | 3 | 2 | 4 | 2 | 3 | 4 |
| Category Rank | 20/ 29 | 14/ 29 | 4/ 32 | 12/ 34 | 24/ 35 | 11/ 38 | 31/ 40 | 13/ 41 | 26/ 48 | 48/ 50 |
Best Calendar Return (Last 10 years)
19.22% (2021)
Worst Calendar Return (Last 10 years)
-15.18% (2016)
Asset Allocation
| Name | Percent |
|---|---|
| US Equity | 59.40 |
| International Equity | 39.91 |
| Cash and Equivalents | 0.68 |
| Other | 0.01 |
Sector Allocation
| Name | Percent |
|---|---|
| Healthcare | 84.10 |
| Consumer Services | 3.46 |
| Industrial Goods | 2.35 |
| Consumer Goods | 1.23 |
| Cash and Cash Equivalent | 0.68 |
| Other | 8.18 |
Geographic Allocation
| Name | Percent |
|---|---|
| North America | 60.08 |
| Europe | 28.50 |
| Asia | 2.92 |
| Africa and Middle East | 1.38 |
| Other | 7.12 |
Top Holdings
| Name | Percent |
|---|---|
| ROCHE HOLDING AG | - |
| Eli Lilly and Co | - |
| AstraZeneca PLC | - |
| Abbvie Inc | - |
| Stryker Corp | - |
| Novartis AG Cl N | - |
| Gilead Sciences Inc | - |
| Thermo Fisher Scientific Inc | - |
| Boston Scientific Corp | - |
| Ucb SA | - |
Equity Style
Fixed Income Style
Risk vs Return (3 Yr)
Fidelity Global Health Care Fund Series B
Median
Other - Health Care Equity
3 Yr Annualized
| Standard Deviation | 11.76% | 12.44% | 12.05% |
|---|---|---|---|
| Beta | 1.00 | 1.02 | 0.99 |
| Alpha | -0.05 | -0.05 | -0.03 |
| Rsquared | 0.93% | 0.93% | 0.91% |
| Sharpe | -0.34 | -0.11 | 0.38 |
| Sortino | -0.37 | -0.16 | 0.43 |
| Treynor | -0.04 | -0.01 | 0.05 |
| Tax Efficiency | - | 100.00% | 100.00% |
| Volatility |
|
|
|
Risk Rating
Annualized Key Ratio Period Comparison
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 11.91% | 11.76% | 12.44% | 12.05% |
| Beta | 0.88 | 1.00 | 1.02 | 0.99 |
| Alpha | -0.11 | -0.05 | -0.05 | -0.03 |
| Rsquared | 0.96% | 0.93% | 0.93% | 0.91% |
| Sharpe | -0.61 | -0.34 | -0.11 | 0.38 |
| Sortino | -0.81 | -0.37 | -0.16 | 0.43 |
| Treynor | -0.08 | -0.04 | -0.01 | 0.05 |
| Tax Efficiency | - | - | 100.00% | 100.00% |
Fundata ESG Metrics
Fundata ESG Score
The E, S, and G scores are averaged for each security in the portfolio, to arrive at an ESG score for each security. We take the portfolio weighted average of the ESG scores for each fund and rank them against their peers to arrive at the Fundata ESG Score from 0-100.
Fundata E Score
Three scores under the Environment bucket are averaged to yield the Fundata Environment Score for each fund from 0-100: (1) Pollution Prevention, (2) Environmental Transparency, (3) Resource Efficiency.
Fundata S Score
Six scores under the Social bucket are averaged to yield the Fundata Social Score for each fund from 0-100. (1) Compensation and Satisfaction, (2) Diversity and Rights, (3) Education and Work Conditions, (4) Community and Charity, (5) Human Rights, (6) Sustainability Integration.
Fundata G Score
Three scores under the governance bucket are averaged to yield the Fundata Governance Score for each fund from 0-100: (1) Board Effectiveness, (2) Management Ethics, (3) Disclosure and Accountability.
Powered by OWL Analytics. For more information, please contact Fundata Canada.
Fund Details
| Start Date | June 05, 1997 |
|---|---|
| Instrument Type | Mutual Fund |
| Share Class | Commission Based Advice |
| Legal Status | Trust |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Annual |
| Assets ($mil) | - |
Fund Codes
| FundServ Code | Load Code | Sales Status |
|---|---|---|
| FID299 |
Investment Objectives
The Fund aims to achieve long-term capital growth. It invests primarily in equity securities of companies anywhere in the world that design, make or sell products or services related to health care and medicine.
Investment Strategy
To meet the Fund’s objectives, the portfolio management team: Invests in companies in the health care industry, including biotechnology firms, and health management organizations and companies involved in hospital management, medical products, and pharmaceuticals. When buying and selling equity securities, may consider other factors about a company, including: >Financial condition. >Industry position. >Economic and market conditions. >Growth potential. >Earnings estimates. >Quality of management
Portfolio Management
| Portfolio Manager |
Fidelity Investments Canada ULC
|
|---|---|
| Sub-Advisor |
FIL Limited |
Management and Organization
| Fund Manager |
Fidelity Investments Canada ULC |
|---|---|
| Custodian |
State Street Trust Company Canada |
| Registrar |
Fidelity Investments Canada ULC |
| Distributor |
Fidelity Investments Canada ULC |
Investment Minimums
| RSP Eligible | Yes |
|---|---|
| PAC Allowed | Yes |
| PAC Initial Investment | 25 |
| PAC Subsequent | 25 |
| SWP Allowed | Yes |
| SWP Min Balance | 5,000 |
| SWP Min Withdrawal | 50 |
Fees
| MER | 2.24% |
|---|---|
| Management Fee | 1.85% |
| Load | Back Fee Only |
| FE Max | 5.00% |
| DSC Max | - |
| Trailer Fee Max (FE) | 1.00% |
| Trailer Fee Max (DSC) | - |
| Trailer Fee Max (NL) | - |
| Trailer Fee Max (LL) | - |
Try Fund Library Premium
Free with a 30 day trial!
Gain access to
- Unlimited Watchlists
- Advanced Search Filtering
- Fund Comparisons
- Portfolio Scenarios
- Customizable PDF Reports
- Portfolio Rebalancer new
